Novel Bioactive Proteasome Inhibitor Ixazomib 1201902-80-8

Basic Info

Model No.: 1201902-80-8

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

We supply large quantity of IBRUTINIB AND and intermediate  5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine CAS

We offers cas 1201902-80-8 Ixazomib in bulk ,MLN9708,MLN-9708,MLN 9708(1201902-80-8) also known as ixazomib, novel orally bioactive proteasome inhibitor.

MLN2238 CAS 1201902-80-8 shows both greater maximum and sustained tumor proteasome inhibition compared with bortezomib in both CWR22 and WSUDLCL2 xenografts models. Ixazomib has the Molecular Weight (MW):517.12. Weight Formula. C20H23BCl2N2O9. Purity: >=98%. Appearance: Solid. Solubility: DMSO. Storage: -20°C.

Thera. Category: Anti-cancer

Cas No.: 1201902-80-8

Synonym: 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid;MLN9708;MLN9708,MLN-9708,MLN 9708;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid MLN9708;Ixazomib Citrate

Molecular Formula:  C20H23BCl2N2O9

Molecular Weight: 303.31802

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage:

MLN9708 CAS 1201902-80-8 is a selective, potent, and reversible proteasome inhibitor.

Related intermediate:

1) 179324-87-9 (1R)-(S)-PINANEDIOL 1-AMMONIUM TRIFLUOROACETATE-3-METHYLBUTANE-1-BORONATE

2) 667403-46-5 CHEMBRDG-BB 7959525